Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.

Authors :: Monneret G
de Marignan D
Coudereau R
Bernet C
Ader F
Frobert E
Gossez M
Viel S
Venet F
Wallet F
Source :: Cellular & molecular immunology [Cell Mol Immunol] 2020 Sep; Vol. 17 (9), pp. 1001-1003. Date of Electronic Publication: 2020 Jul 29.
Publication Year :: 2020

Subjects :: Acute Kidney Injury diagnosis
Acute Kidney Injury pathology
Aged
Anti-Bacterial Agents therapeutic use
Antifungal Agents therapeutic use
Betacoronavirus immunology
COVID-19
Compassionate Use Trials
Coronavirus Infections drug therapy
Coronavirus Infections genetics
Coronavirus Infections virology
Critical Illness
Fatal Outcome
Humans
Intensive Care Units
Lymphopenia drug therapy
Lymphopenia genetics
Lymphopenia virology
Male
Pandemics
Pneumonia, Ventilator-Associated diagnosis
Pneumonia, Ventilator-Associated drug therapy
Pneumonia, Ventilator-Associated etiology
Pneumonia, Ventilator-Associated pathology
Pneumonia, Viral drug therapy
Pneumonia, Viral genetics
Pneumonia, Viral virology
Respiration, Artificial adverse effects
SARS-CoV-2
Severe Acute Respiratory Syndrome drug therapy
Severe Acute Respiratory Syndrome genetics
Severe Acute Respiratory Syndrome virology
Betacoronavirus pathogenicity
Coronavirus Infections immunology
Immunologic Factors therapeutic use
Interleukin-7 therapeutic use
Lymphopenia immunology
Pneumonia, Viral immunology
Severe Acute Respiratory Syndrome immunology

Full Text Access

Tools